The severity of executive dysfunction among different PD-MCI subtypes

被引:3
|
作者
Kormas, Constantinos [1 ]
Zalonis, Ioannis [1 ]
Evdokimidis, Ioannis [1 ]
Kapaki, Elisabeth [1 ]
Potagas, Constantin [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, 72-74 Vas Sophias Ave, Athens 11528, Greece
关键词
Executive functions; inhibitory control; mental flexibility; mild cognitive impairment; Parkinson's disease; MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; NORMATIVE DATA; POPULATION; DEMENTIA;
D O I
10.1080/23279095.2020.1786832
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim to examine the severity of executive dysfunction among different Parkinson's disease (PD)-mild cognitive impairment (MCI) subtypes in the early stages of the disease. The final sample consisted of 65 patients with mild PD progression. Based on neuropsychological measures, our sample was categorized into three PD-MCI subtypes: (1) PD-MCI executive group (n = 24), (2) PD-MCI executive plus memory group (n = 22), and (3) PD-MCI executive plus visuospatial group (n = 19). Patients' executive functions were evaluated with the Trail Making Test-Part B (TMT-B) and Stroop Neuropsychological Screening Test (SNST) for mental flexibility and inhibitory control, respectively. One-way ANOVA results indicated significant differences among the three subgroups on TMT-B and SNST performance.Post hocTukey honestly significant different (HSD) tests revealed that the PD-MCI executive plus visuospatial group had lower performances on both executive measures than the other two groups. Contrastingly, no significant differences were observed between the PD-MCI executive group and PD-MCI executive plus memory group. Our results indicated that the severity of executive dysfunction varies across different PD-MCI subtypes. These findings are discussed within the framework of the dual syndrome hypothesis and highlight the utility of determination of executive impairment severity for effective clinical management of patients with PD.
引用
收藏
页码:546 / 550
页数:5
相关论文
共 50 条
  • [21] Risk of Parkinson's disease dementia related to level I MDS PD-MCI
    Hoogland, Jeroen
    Boel, Judith A.
    de Bie, Rob M. A.
    Schmand, Ben A.
    Geskus, Ronald B.
    Dalrymple-Alford, John C.
    Marras, Connie
    Adler, Charles H.
    Weintraub, Daniel
    Junque, Carmen
    Pedersen, Kenn F.
    Mollenhauer, Brit
    Goldman, Jennifer G.
    Troster, Alexander I.
    Burn, David J.
    Litvan, Irene
    Geurtsen, Gert J.
    MOVEMENT DISORDERS, 2019, 34 (03) : 430 - 435
  • [22] Accuracy of the MoCA in Detecting PD-MCI in the Ontario Neurodegenerative Disease Research Initiative study
    Zaidi, K. B.
    Marras, C.
    Troyer, A.
    Lang, A.
    Masellis, M.
    Grimes, D.
    Kwan, D.
    Orange, J. B.
    Roberts, A.
    Levine, B.
    Jog, M.
    Steeves, T.
    Tan, B.
    McLaughlin, P.
    MOVEMENT DISORDERS, 2019, 34 : S719 - S720
  • [23] Electrocortical connectivity and non-linear quantitative analysis of EEG signal in PD-MCI
    Mostile, G.
    Giuliano, L.
    Monastero, R.
    Luca, A.
    Cicero, C. E.
    Donzuso, G.
    Dibilio, V.
    Baschi, R.
    Terranova, R.
    Sciacca, G.
    Sofia, V.
    Fierro, B.
    Zappia, M.
    Nicoletti, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 517 - 517
  • [24] Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical Modifications
    Devignes, Quentin
    Daoudi, Sami
    Viard, Romain
    Lopes, Renaud
    Betrouni, Nacim
    Kuchcinski, Gregory
    Rolland, Anne-Sophie
    Moreau, Caroline
    Defebvre, Luc
    Bardinet, Eric
    Bonnet, Marie
    Brefel-Courbon, Christine
    Delmaire, Christine
    El Mountassir, Fouzia
    Fluchere, Frederique
    Fradet, Anne
    Giordana, Caroline
    Hainque, Elodie
    Houvenaghel, Jean-Francois
    Jarraya, Bechir
    Klinger, Helene
    Maltete, David
    Marques, Ana
    Meyer, Mylene
    Rascol, Olivier
    Rouaud, Tiphaine
    Tir, Melissa
    Wirth, Thomas
    Corvol, Jean-Christophe
    Devos, David
    Dujardin, Kathy
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (05) : 1507 - 1526
  • [25] Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
    Ann J. Jones
    Roeline G. Kuijer
    Leslie Livingston
    Daniel Myall
    Kyla Horne
    Michael MacAskill
    Toni Pitcher
    Paul T. Barrett
    Tim J. Anderson
    John C. Dalrymple-Alford
    Translational Neurodegeneration, 6
  • [26] PD-MCI is frequent in candidates to subthalamic deep brain stimulation and is associated with structural brain alterations
    Dujardin, K.
    Devignes, Q.
    Daoudi, S.
    Viard, R.
    Lopes, R.
    Betrouni, N.
    Kuchcinski, G.
    Rolland, A. S.
    Corvol, J. C.
    Devos, D.
    MOVEMENT DISORDERS, 2022, 37 : S532 - S533
  • [27] Are There Executive Dysfunction Subtypes Within ADHD?
    Roberts, Bethan A.
    Martel, Michelle M.
    Nigg, Joel T.
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (04) : 284 - 293
  • [28] Diagnosing PD-MCI by MDS Task Force Criteria: How Many and Which Neuropsychological Tests?
    Goldman, Jennifer G.
    Holden, Samantha
    Ouyang, Bichun
    Bernard, Bryan
    Goetz, Christopher G.
    Stebbins, Glenn T.
    MOVEMENT DISORDERS, 2015, 30 (03) : 402 - 406
  • [29] Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort
    Jones, Jacob D.
    Kuhn, Taylor P.
    Szymkowicz, Sarah M.
    PARKINSONISM & RELATED DISORDERS, 2018, 47 : 3 - 7
  • [30] PD-MCI颈内动脉支架植入术后认知功能变化研究
    刘俊中
    王天玉
    魏孟丽
    中国实用神经疾病杂志, 2014, 17 (12) : 70 - 72